Q4 2024 Holdings
Filed 2025-02-14 | 73 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | NOTE11/1 | 40131MAB5 | $226.0M | $268,252,000 | 6.7% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $148.1M | $140,838,000 | 4.4% |
| Novocure LTD | NOTE11/0 | 67011XAB9 | $134.5M | $140,834,000 | 4.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $123.1M | 901,790 | 3.6% |
| Repligen Corp | NOTE 1.000%12/1 | 759916AD1 | $114.8M | $112,000,000 | 3.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $114.2M | 2,913,964 | 3.4% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $113.2M | $114,206,000 | 3.4% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $98.3M | $116,381,000 | 2.9% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $96.9M | 2,977,951 | 2.9% |
| CG Oncology Inc(CGON) | COM | 156944100 | $94.2M | 3,283,317 | 2.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $87.0M | 2,847,931 | 2.6% |
| Ironwood Pharmaceuticals Inc | NOTE 1.500% 6/1 | 46333XAH1 | $85.2M | $92,740,000 | 2.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $78.2M | 375,179 | 2.3% |
| Dexcom Inc | NOTE 0.375% 5/1 | 252131AM9 | $74.4M | $82,700,000 | 2.2% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $69.8M | 1,540,362 | 2.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $68.3M | 3,452,447 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $67.0M | 2,098,866 | 2.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $63.6M | 705,391 | 1.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $62.3M | 2,332,196 | 1.8% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $61.8M | 4,873,853 | 1.8% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $60.0M | 2,578,404 | 1.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $59.5M | 1,479,666 | 1.8% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $57.5M | 922,100 | 1.7% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $55.1M | $58,217,000 | 1.6% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $54.4M | 293,410 | 1.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $49.7M | 80,766 | 1.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $46.7M | 89,754 | 1.4% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $46.0M | $53,594,000 | 1.4% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $45.5M | 8,353,287 | 1.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $44.4M | 364,900 | 1.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $43.7M | 183,828 | 1.3% |
| Glaukos Corp(GKOS) | COM | 377322102 | $43.3M | 288,876 | 1.3% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $43.2M | 4,105,726 | 1.3% |
| Repligen Corp(RGEN) | COM | 759916109 | $40.9M | 283,823 | 1.2% |
| Paragon 28 Inc(FNAUSD) | COM | 69913P105 | $39.6M | 3,834,809 | 1.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $39.3M | 75,300 | 1.2% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $39.1M | 4,256,490 | 1.2% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $35.3M | 309,865 | 1.0% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $34.9M | 2,000,659 | 1.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $31.4M | 200,500 | 0.9% |
| Harrow Inc(HROW) | COM | 415858109 | $30.4M | 907,039 | 0.9% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $30.0M | 1,894,439 | 0.9% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $27.1M | 1,147,676 | 0.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $26.3M | 1,206,589 | 0.8% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $25.7M | 1,107,770 | 0.8% |
| Immatics N.v(IMTX) | SHS | N44445109 | $24.9M | 3,503,965 | 0.7% |
| Geron Corp(GERN) | COM | 374163103 | $24.8M | 7,006,315 | 0.7% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $24.1M | 5,440,277 | 0.7% |
| Bruker Corp(BRKR) | COM | 116794108 | $20.7M | 353,200 | 0.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $19.8M | 353,000 | 0.6% |